Umbilical cord blood-derived cytokine-induced killer cells (Zhongyuan Union/Alliancells)

N/A

Report date: 2024/01/02 20:03:52

Base Information

Drug NameUmbilical cord blood-derived cytokine-induced killer cells (Zhongyuan Union/Alliancells)
Drug Alias NameN/A
ClassificationCell and gene therapy > Cell therapy
Mechanisms of ActionUpdating
TargetsNot applicable
Therapy Area/IndicationsLung NeoplasmsCarcinoma, Renal CellCarcinoma, Hepatocellular
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaPending
Originator CompaniesVcanbio Cell & Gene Engineering Corp Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAlliancells-Purui Biocience Co LtdVcanbio Cell & Gene Engineering Corp Ltd
Active IndicationsN/A
Inactive IndicationsLung NeoplasmsCarcinoma, Renal CellCarcinoma, Hepatocellular

Other Information

ATC CodeN/A
Related LinksN/A